A matched-pair analysis of transplant-related outcomes was carried out in 116 of 255 consecutive patients transplanted from HLA identical sibling (n=58) or haploidentical related donor (n=58). The two patient series were matched with 9 variables: period of transplant, patient and donor age, gender, diagnosis, disease phase, conditioning regimen, donor/recipient sex and CMV status combinations. As graft-versus-host disease prophylaxis, all patients received the standard cyclosporine and methotrexate association with the addition of anti-thymocyte globulins, mycophenolate-mofetil and Basiliximab in haploidentical, unmanipulated bone marrow recipients. Anti-infectious management, transfusion policy and supportive care were identical for all patients. By comparing the two patient series, no statistically significant difference was observed for the cumulative incidence of advanced acute and extensive chronic GVHD, TRM and relapse. With a median follow-up of 3.5 years, the 5-year DFS was 37±6% and 36±6% for HLA Id-sib and haplo recipients, respectively. The results of transplant from HLA id-siblings and haploidentical donors are comparable. Regardless of the HLA matching, other factors known to affect the transplant outcomes such as donor-recipient age, sex and CMV status combinations might drive the search for the best donor.

Arcese, W., Cerretti, R., Sarmati, L., Cudillo, L., De Angelis, G., Mariotti, B., et al. (2020). MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2020.02.005].

MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

Arcese, William;Cerretti, Raffaella;Sarmati, Loredana;Cudillo, Laura;De Fabritiis, Paolo;Cupelli, Luca;Annibali, Ombretta;Adorno, Gaspare;Miccichè, Silvia;Andreoni, Massimo;Picardi, Alessandra
2020-02-14

Abstract

A matched-pair analysis of transplant-related outcomes was carried out in 116 of 255 consecutive patients transplanted from HLA identical sibling (n=58) or haploidentical related donor (n=58). The two patient series were matched with 9 variables: period of transplant, patient and donor age, gender, diagnosis, disease phase, conditioning regimen, donor/recipient sex and CMV status combinations. As graft-versus-host disease prophylaxis, all patients received the standard cyclosporine and methotrexate association with the addition of anti-thymocyte globulins, mycophenolate-mofetil and Basiliximab in haploidentical, unmanipulated bone marrow recipients. Anti-infectious management, transfusion policy and supportive care were identical for all patients. By comparing the two patient series, no statistically significant difference was observed for the cumulative incidence of advanced acute and extensive chronic GVHD, TRM and relapse. With a median follow-up of 3.5 years, the 5-year DFS was 37±6% and 36±6% for HLA Id-sib and haplo recipients, respectively. The results of transplant from HLA id-siblings and haploidentical donors are comparable. Regardless of the HLA matching, other factors known to affect the transplant outcomes such as donor-recipient age, sex and CMV status combinations might drive the search for the best donor.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/15
English
Haplo vs Identical Sibling; Matched pair analysis; hematological malignancies
Arcese, W., Cerretti, R., Sarmati, L., Cudillo, L., De Angelis, G., Mariotti, B., et al. (2020). MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2020.02.005].
Arcese, W; Cerretti, R; Sarmati, L; Cudillo, L; De Angelis, G; Mariotti, B; Bruno, A; Mangione, I; Rapanotti, C; Andreani, M; De Fabritiis, P; Dentamaro, T; Cupelli, L; Mengarelli, A; Marchesi, F; Tirindelli, Mc; Annibali, O; Tafuri, A; Ferrari, A; Cedrone, M; Anaclerico, B; Adorno, G; Miccichè, S; Andreoni, M; Picardi, A
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/232692
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact